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REVIEWS 
Importance of Epidemiology and Biostatistics in Deciding Clinical 
Strategies for Using Diagnostic Tests: A Simplified Approach Using 
Examples From Coronary Artery Disease 
RANDOLPH E. PATTERSON, MD, FACC, STEVEN F. HOROWITZ, MD, FACC* 
The explosion of costly new medical diagnostic technologies 
demands a common sense approach to help physicians 
decide appropriate indications and strategies for use of 
these tests. This simple, nonmathematical review focuses on 
the assessment of coronary artery disease, but the approach 
can he generalized to other medical problems. This clinical 
approach to diagnostic testing strategies is based on seven 
sequential questions: 1. What is the clinical probability that 
this patient has a specific disease characteristic based on 
clinical data? 2. What is the overall objective for manage- 
ment of this patient based on the overall status of the 
patient? 3. Most importantly, what specific questions need 
to be answered about the patient’s condition before the 
physician can recommend the most appropriate manage- 
ment (e.g., whether the patient has coronary disease, 
whether an anatomic lesion is functionally significant, 
whether a myocardial region is reversibly ischemic or 
irreversibly infarcted, whether a particular therapy has 
had good or bad effects or what is the patient’s prognosis)? 
The key point is for the physician to formulate a specific 
clinical question about the patient before the test. 4. The 
physician must then ask how well does the test answer the 
particular clinical question about the patient. Here the 
physician needs to understand the sensitivity and specificity 
of the test, especially because they are influenced by various 
clinical biases. 5. Next, the physician must ask how to 
interpret the reliability of a positive or negative test result 
in the individual patient. This requires understanding 
predictive value and predictive error of a given result and 
how they are influenced by the clinical data as described by 
Bayes’ theorem. 6. Next, the physician must ask what 
further tests or therapies will be recommended for the 
patient. The physician can estimate in advance how dif- 
ferent test results would alter management plans and he can 
then allow this estimate to help determine indications for 
the test. There is some controversy concerning whether to 
use Bayes’ theorem or multivariate analysis to estimate the 
final probability of a disease characteristic. 7. Finally, in 
this era of quality assurance, professional review and cost 
containment, it behooves each physician to ask whether the 
data provided by the particular tests were worth the cost, 
inconvenience and risk for that particular patient. 
(J Am Co11 Cardiol1989;13:1653-65) 
A 3.5 year old personal friend calls you in considerable 
distress because his own physician has told him that he 
has a “positive stress test.” You know that your 
friend has no symptoms and, on questioning, he has no 
risk factors. In addition, he regularly beats you in 
tennis. Your first question is, “Why on earth did 
anybody do a stress test on you, anyway?” 
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The preceding anecdote brings up a question that is becom- 
ing increasingly important because of the widespread devel- 
opment and application of numerous expensive noninvasive 
tests to “screen” for coronary artery disease. Common 
sense and pressure from third party payers both indicate the 
need for physicians to develop a systematic approach to 
diagnostic test ordering. A rational approach to the use of 
noninvasive exercise tests in the overall management of 
people with known or suspected coronary artery disease can 
be developed on the basis of simple concepts of clinical 
epidemiology and biostatistics. Coronary artery disease is 
used here as an example, but the general approach to the 
problem can be readily extrapolated to tests in other areas of 
medicine. The approach offered here allows each physician 
to develop his or her own personal guidelines for using these 
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Table 1. Clinical Approach to Use of Tests for Coronary 
Artery Disease 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
Make a clinical estimate of the probability of disease based on history, 
physical examination and preliminary laboratory tests. 
Formulate options in further management. 
Define the specijc question that needs to be answered to decide among 
management options. 
Define performance of tests available to answer the specific question 
(sensitivity and specificity). 
Synthesize test results with preliminary clinical estimate to give best 
answer to the specific question (predictive value and error). 
Determine which further tests or therapies are needed. on the basis of 
clinical data and initial test results. 
Review whether the testing strategy used was optimal for each 
individual patient. 
tests (Table 1) on the basis of individual responses to the 
seven questions presented in the text. Individual physicians 
should answer these questions somewhat differently to make 
their test ordering practices consistent with their view of the 
roles of surgery and angioplasty in coronary disease. 
We have emphasized the use of tests to diagnose the 
presence or absence of coronary disease because clinical 
studies to date have provided the best data for that question. 
Finally, apologies must be offered to the serious statistician 
or epidemiologist because this review is designed to simplify 
this very complex but important area. We hope to introduce 
this important subject to new readers who could, then, read 
the more sophisticated, mathematically oriented reports in 
this field. 
Question 1 
What Is the Clinical Probability That This 
Patient Has Coronary Artery Disease or the 
Speci’c Disease Characteristic? 
By assessing the patient’s age, gender, number of risk 
factors (l-3) and specific characteristics of symptoms (4), it 
is possible to roughly estimate the probability of coronary 
artery disease. Figure 1 offers a convenient summary of the 
probability of coronary artery disease (5) predicted by 
simple clinical information cited in Tables 2 and 3. These 
data have been derived primarily from investigations such as 
the Framingham Study (1,2), which defined the incidence of 
new (first) coronary events over a 7 year follow-up period in 
a large community-based population, and from a summary of 
the probability of coronary disease based on chest pain 
reviewed by Diamond and Forrester (4). A more precise, 
linear relation with serum cholesterol was demonstrated by 
Stamler et al. (3), using a database of >356,000 patients 
studied prospectively. This incidence of new coronary 
events over 7 years correlates closely with the prevalence 
of coronary disease found on coronary arteriography at a 
single point in time (4). Although incidence (new events 
CLINICAL DATA 
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CLINICAL PROBABILITY OF CORONARY DISEASE 
Figure 1. Use of clinical data to estimate the probability of coro- 
nary artery disease. Clinical data include gender (women are shown 
in the upper panel, men are shown in the lower panel), age (in- 
creasing up vertical axis), number of risk factors for asymptomatic 
people (0 to 5 of the following: diabetes, hyperlipidemia, hyperten- 
sion, smoking and at rest electrocardiographic abnormality of ST-T 
waves). Symptoms are defined as nonanginal chest pain (NACP), 
atypical chest pain (ATCP) and typical angina pectoris (TAP). The 
probability of coronary artery disease increases from left to right, 
and the 95% confidence intervals are shown as the widths of the bar. 
over time) is not the same as prevalence (disease present at 
one time), their rates are nearly identical in this circum- 
stance (4). 
This estimate of the likelihood of coronary artery disease 
before any test is performed is crucial, both for making 
further decisions on the need for tests (6,7) and for deter- 
mining the final likelihood of coronary artery disease, based 
on a synthesis of clinical and exercise test data. All clinicians 
will recognize the approximate nature of this estimate be- 
Table 2. Clinical Data Needed to Assess Risk Factors for 
Coronary Artery Disease 
1, History of chest discomfort. 
Provoked by exercise. 
Located in center of chest. 
Relieved after 2 to 10 min by rest. 
2. History of smoking. 
3. Physical examination-blood pressure. 
4. Laboratory data-blood sugar. 
5. Laboratory data-serum cholesterol. 
6. Laboratory data-rest ECG. 
ECG = electrocardiogram. 
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Table 3. Criteria to Classify Chest Discomfort (13) 
Criteria 
I. Precipitated by exercise. 
2. Brief duration (2 to IS mitt). 
3. Relieved promptly by rest or nitroglycerin. 
4. Substernal location. 
5. Radiation from chest to jaw, left arm or neck. 
6. Absence of other causes for pain. 
Classification 
1. Typical angina pectoris 
Criteria I to 3 all positive. 
Any four criteria positive. 
II. Atypical chest pain 
Any two criteria positive. 
Only criteria 4 to 6 positive. 
III. Nonanginal chest pain 
Only one criterion positive. 
cause of the variability of the patient’s history and the 
clinical assessment of risk factors. 
Question 2 
What Is the Overall Objective for Management 
of This Patient? 
Although the objective for most patients would be to 
relieve symptoms if present and to prolong life if possible, 
objectives must be individualized for each person. The 
physician must consider the patient’s age, life style, other 
medical conditions and the patient’s attitude toward invasive 
therapies. In addition, each physician should make decisions 
about ordering tests that are consistent with his or her 
personal opinions regarding the safety and accuracy of the 
particular tests and therapies within the local medical com- 
munity. 
The physician’s philosophy is of crucial importance in 
determining how strongly he or she needs to know the 
information available from each diagnostic test. For exam- 
ple, the physician who believes that coronary artery bypass 
graft surgery or percutaneous transluminal coronary angio- 
plasty is useful only for patients who have disabling symp- 
toms despite maximal medical therapy (8,9) should use a 
conservative approach in ordering tests that are unlikely to 
affect management. On the other hand, physicians who are 
convinced that coronary artery bypass surgery or coronary 
angioplasty can prolong life in most patients with coronary 
artery disease (10,ll) should be aggressive in seeking evi- 
dence for coronary artery disease in their patients. 
Similarly, the need to know whether coronary artery 
disease is present is dependent on individual patient charac- 
teristics. An obvious example is that the need to know might 
be very great in a 40 year old airline pilot with chest pain and 
not very great in a demented 85 year old cancer patient with 
typical angina. This need can only be determined if the 
Table 4. Indications for Tests: Examples of Specific Questions 
That Need to Be Answered About the Patient’s Condition 
I. Is coronary artery disease present or absent? 
2. Is anatomic coronary stenosis observed on angiography physiologically 
significant? 
3. What is the patient’s prognosis? 
4. Are there regions of viable but potentially ischemic myocardium in the 
patient’s heart after a myocardial infarction’? 
5. What is the patient’s response to a particular therapeutic intervention? 
patient’s medical and social condition are thoroughly under- 
stood by the responsible physician. Thus, the need to know 
must influence the decision of whether to proceed with 
further diagnostic testing and, if so, which test to use. 
Question 3 
What Specijic Questions Need to Be Answered 
About the Patient’s Condition Before the 
Physician Can Recommend the Most 
Appropriate Management (Table 4)? 
The physician must formulate one or more specific clini- 
cal questions that need to be answered when referring a 
patient for a test. The questions should evolve from the 
overall goal of clinical management to provide focus and 
organization to the evaluation. There are several possible 
questions (Table 4). The present review focuses on the first 
question because the best data are available to determine the 
presence or absence of coronary artery disease from nonin- 
vasive studies. 
Most of the newer technologies, such as nuclear cardiol- 
ogy tests, have been assessed by comparing their ability to 
identify the presence or absence of coronary artery disease 
(12,13) or to identify patients with high risk coronary anat- 
omy (14,15) using coronary angiography as the reference or 
“gold” standard method. There are other, potentially more 
important clinical questions that need to be answered. For 
example, the ability of these tests to assess the functional 
significance of a lesion observed on coronary angiography is 
only partially defined. One must be aware that the reliability 
of an estimate of whether a lesion is significant may be lower 
than the reliability of a prediction of the presence or absence 
of coronary artery disease. Also, the physician might want to 
assess differences in coronary collateral perfusion distal to 
similar anatomic lesions (16,171. The most meaningful way 
to define the significance of an anatomic lesion may be to 
define the impact of the lesion on the patient’s prognosis. 
In recent years, several centers (18-24) have presented 
data concerning the ability of exercise stress tests to predict 
prognosis. Because cardiac events such as death or new 
myocardial infarction occur with a relatively low frequency, 
long-term follow-up study of large numbers of patients is 
required. The natural history of the disease is now frequently 
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Table 5. Definitions of Sensitivity, Specificity, Predictive Value 
and Predictive Error (based on a two by two table) 
Disease 
Present 
Disease 
Absent Totals 
Test positive 
Test negative 
Total 
True positive 
False negative 
All with 
disease 
False positive 
True negative 
All with no 
disease 
All positive tests 
All negative tests 
All patients 
tested 
altered by surgery or angioplasty. For these reasons, the 
ability of a noninvasive stress test to predict prognosis is less 
easily defined than the ability to identify the presence or 
absence of coronary artery disease. 
In trying to decide whether to recommend invasive 
interventions such as bypass surgery or angioplasty for a 
patient with prior myocardial infarction, it is essential to 
distinguish infarction from ischemia because interventions 
can only help ischemia. The best clinical technique that is 
widely available for this purpose is observing redistribution 
to fill in a defect from stress to delay images on thallium-201 
imaging ( 12). 
Once the variability of individual tests is understood, 
assessing the response to therapy may be one of the best 
uses of these tests because one can compare the test in the 
same patient at different points in time (25-28). Once the 
physician formulates a clear clinical question for the pa- 
tient’s management, it is relatively easy to decide which 
tests will contribute information useful for clinical decision- 
making. 
Question 4 
How Well Does the Test Answer the Particular 
Clinical Question About the Patient? 
Test performance is best described by statistical expres- 
sions of sensitivity and specificity (Table 5, Fig. 2). These 
two statistical expressions must be defined for each partic- 
ular test in a group of patients who are known by some 
independent reference method to have or not have the 
characteristic for which testing is performed. 
Sensitivity is defined as the probability that the test will be 
positive in a group of patients who are known to have 
coronary artery disease by an independent method such as 
coronary angiography. Stated another way, sensitivity is the 
percent of patients with disease who can be identified by a 
positive test (29,30). 
SpeciJcity is defined as the probability that the test will be 
negative in a group of patients known not to have coronary 
artery disease by angiography. Stated another way, speci- 
ficity is the percent of patients who do not have coronary 
artery disease who can be identified correctly by a negative 
test (29,30). Sensitivity and specificity can also be calculated 
to define the ability of tests to define characteristics such as 
SENSITIVITY = 
% of Patients with CAD Who are Detected by (+) Test 
FN 
= 75175 + 25 = 75% 
loo Pts 
with CAD 
SPECIFICITY = 
% of Patients without CAD Who are Identified by (-) Test 
= 65165 t 35 = 65% 
loo Pts 
without CAD 
Figure 2. Pie diagrams show definitions of sensitivity and speci- 
ficity in hypothetical groups of 100 people known to have coronary 
artery disease (CAD) by coronary angiography (sensitivity, above) 
or of 100 people known not to have coronary disease (specificity, 
below). These hypothetical values are for exercise electrocardio- 
graphy. F = false; N = negative; P = positive; T = true; t = 
positive test: - = negative test. 
the presence or absence of a coronary event during the 
follow-up period. 
Published values of sensitivity and specificity for various 
noninvasive tests may not always agree with local clinical 
experience because of a variety of factors that can influence 
these variables of test accuracy. 
Nondiagnostic tests. One reason that published values of 
sensitivity and specificity may differ is the method chosen to 
deal with patients who have nondiagnostic test results. 
Nondiagnostic results can occur in 30% to 40% of patients 
having an exercise electrocardiogram (ECG) (13). If patients 
with a nondiagnostic test are excluded in the calculation of 
sensitivity or specificity, test accuracy will be inflated (Fig. 
3). Thus, one factor to search for in published reports of 
sensitivity and specificity of a test is the way the authors 
chose to deal with nondiagnostic test results (13). 
Criteria for a positive test. Another factor that causes 
major differences in sensitivity and specificity values is the 
choice of criteria to interpret a test as positive or negative 
(Fig. 4 and 5) (29,31). For example, if an exercise ECG is 
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Sensitiviry = 
75/75+25-!-30 = 67% 
Specificity = 
65/65+30+35 = 50% 
TP TN 
130 pts. 130 Pts. 
with CAD without CAD 
Figure 3. Effect of including nondiagnostic (non-DX) tests on the 
calculated sensitivity and specificity of exercise electrocardiography 
in the same study group as in Figure 2. Note that adding 30 patients 
with a nondiagnostic test to the denominator decreases both sensi- 
tivity and specificity. Sensitivity and specificity are worse when 
including non-DX tests. t = positive test: - = negative test: other 
abbreviations as in Figure 2. 
read as positive when a patient has >O. 1 mV (I mm) flat 
depression of the ST segment, then the sensitivity might be 
75% and the specificity 65%. If the same exercise ECG is 
read with a new criterion of >0.05 mV (0.5 mm) flat ST 
segment as positive. then more patients with disease would 
have a ‘*positive” test. Thus, the sensitivity of the test 
would increase. Unfortunately, lowering the criterion for 
reading a test as positive also influences specificity (31). 
Because a larger proportion of all tests will now be inter- 
preted as positive (including those of patients without dis- 
ease), the specificity will decrease. Similarly, if one requires 
that the exercise ECG show the stricter criterion of >0.2 mV 
Figure 4. Effect of changing the criterion for reading a test as 
positive (t), using as an example the number of mm ST segment 
depression on electrocardiography (ECG) during exercise (0. I mV/ 
mm). This pie diagram shows the hypothetical distribution of ST 
depression in the 100 people from Figure 3 with known coronary 
artery disease (CAD). On the right is a diagram for the 100 people 
without disease. These data are used to recalculate sensitivity and 
specificity. using different criteria for the number of mm of ST 
depression required to call the test positive. 
Exercise ECG (mm STI) 
,>2.0 mm ,>2.0 mm 
100 Pts 
with CAD 
loo Pts 
without CAD 
Criterion 
for It) ST Sensitivity Specificity 
2 2.0 mm 10% 97% 
> 1 .o mm 75% 65% 
10.5 mm 90% 45% 
MODIFIED RECEIVER - OPERATOR 
CHARACTERISTIC CURVE 
loo- 
25 - 
a.0 mm 
0. I 
0 25 50 75 100 
SPECIFICIN 
Figure 5. Effect of changing criterion for positive (t) test. Data in 
Figure 4 were used to construct a modified receiver-operator char- 
acteristic (ROC) curve showing the inverse relation between sensi- 
tivity and specificity. As the criterion for interpreting the ST 
depression as positive changes from 0.5 to 1.0 to 2.0 mm, the 
sensitivity decreases but specificity increases. The curve is plotted 
here as true positive rate (sensitivity) versus specificity for clarity, 
but is usually plotted as true positive rate (sensitivity) versus false 
positive rate (I - specificity). 
(2.0 mm) ST segment depression to be read as positive, then 
fewer patients with disease will have a positive test and the 
sensitivity will be much lower. In addition, fewer patients 
without disease will have a positive test. so specificity will be 
much higher (29.31). 
This example illustrates the point that the physician 
cannot “get something for nothing” in test accuracy sim- 
ply by changing the criteria for reading the same test data. 
This trade-off is called a receiver-operator characteristic 
(ROC) curve when expressed graphically (29,31) (Fig. 5). 
Changing criteria to increase sensitivity will decrease 
specificity and. similarly, changing criteria to increase spec- 
ificity will decrease sensitivity. The same considerations 
apply to criteria for interpreting any type of test in any 
area of medicine. 
Patient selection (Fig. 6). The sensitivity and specificity of 
a test are assumed not to be influenced by changes in the 
prevalence of disease in the group of patients being tested if 
the patients represent a randomly selected group 
(4,29,32,33). On the other hand, if the group of patients 
tested is influenced by some selection factor, there may be 
systematic changes in sensitivity and specificity. For exam- 
ple, it is common medical practice to select patients for 
cardiac catheterization because of a positive noninvasive 
stress test. For this reason, specificity (probability of a 
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Test (+) Test (-) 
rl=llO n=190 
Test (+)Test (-) 
n=lOO n=20 
Selective referral of 120 pabents 
wth (t) results of noninvasive 
tests for coronary angiogram. 
FP=lO Calculations based on oooulation 
+TN=lO having coronary angiogram. 
-*~~=10 Sensitivity = T+N = & = 900/o 
TP=90 
A Specificity = Tsp = & = 50% 
Test (+) 
n=llO 
True (-) 
n=190 
CE (-) = FP 7 year follow-up of 180 
CE (t) = FN 
n=10 
disease in 15 of the 180 pts 
CE (+I = dark slashed area, 
True Sensitivity = 
TP aqo + TP no ango 
= ,TP ang,o + TP no angto) + (FN a”91c + FN no angle) 
90 + 5 95 
=- 
(90 + 5) + (10 + 10) 
= 63% 
115 
C 
True Speclflcity = 
TN aqo + TN no angle 
= (TN ang,o + TN no anglol + (FP angle + FP no snglo) 
10 + 160 170 =- = 92% 
(10 + 160) + (10 + 6) 165 
Figure 6. Hypothetical illustration of the effects of selecting pa- 
tients from the group undergoing coronary angiography in order to 
calculate sensitivity and specificity. Panel A, Group selected for 
angiography to define the prevalence (presence or absence) of 
coronary artery disease. The top bar shows all 300 hypothetical 
people having non invasive tests and the middle bar shows the 120 
people who were referred for angiography. The bottom bar shows 
how these 120 angiographic results were used to calculate sensitivity 
and specificity based on the angiographic results to establish true (T) 
versus false (F) positive (P) or negative (N). Because there is 
selective referral to angiography of patients with a positive nonin- 
vasive test, the sensitivity is high and the specificity is low. Panel B, 
Data for all patients, including those not referred for angiography. 
The top bar shows all 300 hypothetical people having noninvasive 
tests and the middle bar shows the 180 patients who were not 
referred for angiography (angio). If these patients are followed for 7 
years to determine the incidence of coronary artery disease (which 
corresponds to prevalence in this instance), all patients could be 
grouped into those with versus without disease. Considering all 
patients, including those not referred for angiography, decreases 
sensitivity slightly and increases specificity relative to the group 
selected for angiography. Panel C, Calculation of true sensitivity and 
specificity based on all patients, where results for patients with and 
without angiography are added. Thus, true sensitivity and true 
specificity can be recalculated using all 300 people referred for 
noninvasive tests. Abbreviations as in Figure 2. 
negative test in a person without disease) is usually lower in 
patients selected from a group already referred for cardiac 
catheterization than in normal volunteers without symptoms 
(13). One possible explanation is that some patients with a 
positive noninvasive test but normal coronary arteries may 
have disease detectable by noninvasive tests for myocardial 
dysfunction but not by angiography of large vessels and rest 
ventriculography (34). 
Our group (13) was one of thefirst to note the impact of 
selection bias on the accuracy of the noninvasive diagnosis 
of coronary artery disease. We noted that at one institution 
the proportion of cardiac catheterization studies performed 
for chest pain that revealed normal coronary arteries de- 
creased from 30% in 1976 (before) to 10% in 1978 (after, 
when thallium imaging results were used to select patients 
for catheterization). On the one hand, these findings suggest 
that thallium-201 imaging is clinically useful because many 
patients with negative myocardial imaging results were no 
longer being referred for coronary angiography. The other 
effect of this trend, however, is that many of the people who 
would have had true negative thallium-201 images, thereby 
maintaining specificity of the technique (as defined by car- 
diac catheterization), were systematically excluded from the 
cardiac catheterization laboratory. Indeed, the specificity of 
exercise thallium-201 imaging also decreased (from 100% to 
74%) as the test became more readily accepted as a screen- 
ing tool for catheterization (13). Thus, selective referral of 
people with a positive test both decreases the rate of 
detection of true negative results and increases the rate of 
detection of false positive results in the group, resulting in 
reduced specificity. 
Selection bias could also artificially increase the sensitiv- 
ity by excluding people with a false negative noninvasive test 
from the cardiac catheterization laboratory. In our study 
group described previously (13), the 40 month prognosis was 
excellent for patients with a negative exercise thallium test 
and no cardiac catheterization (22), thus supporting the 
validity of the decision not to perform angiography after a 
negative thallium test. This effect of selection bias was 
discussed at greater length in a report (35) of a declining 
specificity of gated blood pool scintigraphy. Thus, intrinsic 
bias in patient selection can profoundly influence calculated 
test accuracy (36). 
Biased interpretation. Another important question that 
can influence the sensitivity and specificity is whether the 
physician interpreting the test knows clinical information 
about the patient before interpreting the test data. Such prior 
knowledge may create serious bias for the physician inter- 
preting the test (4,29). We use and strongly suggest the 
following approach for physicians who read tests (for exam- 
ple, nuclear cardiology specialists). Readers should initially 
interpret the images without any knowledge of the patient’s 
age, clinical status or exercise test data and commit them- 
selves in writing to an impression to avoid bias. In this way, 
both the referring clinician and the nuclear cardiology 
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1. Pl?EDlCllVE VALUE 
If Test = (+). Whbt ‘is Chance Patient has CAD? 
P.V. = 75175 + 35 = 66% 
= Chance of CAD with 
f+) Test 
110 Pts. 
with (+) tests 
2 PREDlCllVE ERROR 
If Test = (-1. What is Chance Patient has CAL)? 
90 Pk. 
with (-) tests 
P.E = 25/65 + 25 = 26% 
= Chance of CAD 
Despite (-) Test 
Figure 7. Definitions of predictive value and predictive error in the 
110 patients (Pts.) with positive test from Figure 2 (predictive value 
[P.V.], above) or of the 90 people with a negative test from Figure 2 
(predictive error [P.E.], below). The term negative predictive value 
is sometimes used for l-predictive error. Abbreviations as in Figure 
2. 
specialist can offer truly independent opinions. Next, the 
reader and the referring physician can synthesize the re- 
sults of clinical information (Fig. 1) and the noninvasive test 
(Fig. 7) to make a final estimate of the probability of 
coronary artery disease (Fig. 8). The final nuclear cardi- 
ology report should then offer a conclusion that takes 
into account the clinical data. This conclusion might 
include an alternative interpretation of the scan, just as 
long as it is clearly labeled as being influenced by clinical 
data (for example, “in light of the clinical history of a 
60% reduction in diameter of the left anterior descending 
coronary artery, the mild decrease in thallium-201 activity 
in the anterior wall may be physiologically significant”). 
When the nuclear cardiology specialist, however honest 
and well meaning, makes an initial interpretation of the 
images with full knowledge of the patient’s clinical informa- 
tion, the patient may be deprived of two truly independent 
opinions. 
To summarize. it is important that the physician referring 
a patient for a test know the sensitivity and specificity of the 
/ 
/ 
/ 
/ 
‘(-) ST 
I I 
20 40 60 80 
PRE-TEST (Cl~nlcai) 
PROBABILITY OF CAD (:h) 
Figure 8. Use of Bayes’ theorem to calculate the probability of 
coronary artery disease (CAD). Clinical data (pretest probability, 
increasing from left to right) are combined with results of exercise 
electrocardiography (positive [t] or negative [-I ST segment re- 
sponse) to yield final posttest probability (increasing along the 
vertical axis). Four specific patient examples are shown by vertical 
bars, where the height of the solid dark bar shows the results for a 
negative exercise electrocardiogram (ECG) (-) ST, and the clear 
bar shows the results for a positive exercise ECG (t) ST. The 
patient shown on the far left has a very low (1% to 4%) probability 
of coronary artery disease from Figure 1: (that is, a 45 year old [yl 
o] man [m] with no symptoms or risk factors). The second patient 
has a low (1570 to 18%) probability of coronary artery disease; (that 
is, a 45 year old man who is asymptomatic but has three risk factors: 
high blood pressure [HBP], hypercholesterolemia [chol.] and diabe- 
tes mellitus [D.M.]). The third patient has an intermediate (42 to 
47%) probability of coronary artery disease (that is, a 45 year old 
man with atypical chest pain), and the fourth patient has a high (89% 
to 92%) probability of coronary artery disease (that is, a 55 year old 
man with typical angina pectoris). In patients with a diagnostic test 
the sensitivity was 0.84 and specificity was 0.62. Although a positive 
exercise ECG always increased the probability of coronary artery 
disease above that found with a negative test, the posttest or final 
probability of coronary artery disease increased dramatically when 
the clinical picture suggested a higher pretest probability of disease. 
test in his or her community to answer the question being 
posed. Only in this way can the physician judge the reliabil- 
ity of the information received from the test in guiding future 
management of the patient. 
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Question 5 
How Can the Physician Interpret the Reliability 
of a Positive or Negative Test Result in the 
Individual Patient? 
This question is more directly relevant to the care of 
particular patients than was the previous question about test 
performance. To interpret the meaning of a specific positive 
test, one needs to know the predictive value of the test (Fig. 
7). Predictive value is defined as the probability that a patient 
with a positive test actually has coronary artery disease. 
Stated differently, the predictive value is the chance that a 
positive test is correct in identifying coronary disease 
(4,29,30,32,33). On the other hand, predictive error is the 
probability that a person with a negative test actually does 
have coronary disease. The predictive error is the chance 
that a negative test is wrong (4,29,32,33). Another commonly 
used term is negative predictive value, which is 1 .O-predic- 
tive error. 
Bayes’ theorem. Both predictive value and predictive 
error are higher in populations in which the prevalence of 
coronary artery disease is higher (4,29,30,32,36). It makes 
sense that in a group of patients with a higher clinical or 
pretest probability of coronary disease there would be a 
greater chance of an individual patient having such disease 
whether the test is positive (predictive value) or negative 
(predictive error). This is the basic message of Bayes’ 
theorem, as shown in Figures 8 and 9 (4,13,29,30,32,33). 
Two clinical examples to illustrate these issues of predic- 
tive value and predictive error, as described by Bayes’ 
theorem, are simply expressing common sense or good 
clinical judgment. As indicated in Figure 1, a 55 year old man 
with a history typical of angina pectoris has a 90% to 95% 
chance of having coronary artery disease on the basis of 
clinical information alone. In contrast, a 35 year old woman 
without symptoms or risk factors has only a 0.5% to 1.5% 
chance based on clinical information alone. Thus, even if the 
55 year old man with typical angina has a negative exercise 
ECG and the 35 year old woman without symptoms has a 
positive test, the experienced clinician’s estimate of the 
probability of coronary artery disease would not be signifi- 
cantly influenced by test results. 
Figure 8 shows the graph obtained by substituting these 
values of sensitivity and speciJicity in the equation for Bayes’ 
theorem (13). If the 55 year old man has a negative exercise 
ECG, his chance of having coronary artery disease is still 
40% to 50%, whereas the 35 year old woman with a positive 
exercise ECG has only a 2% to 4% chance of having this 
disease. In general, as the pretest probability of coronary 
disease (based on clinical information) increases along the 
horizontal axis, the chance of having coronary disease after 
the test result increases along the vertical axis. Because 
predictive value and predictive error depend critically on the 
prevalence of disease in the group under study, it is mean- 
EFFECTS OF POPULATION PREVALENCE ON 
NON-INVASIVE PREDICTION OF CAD 
Probabilii of CAD 
Robabilii of CAD 
given I- I test - 
CAD PREVALENCE IN FOWLATION (%) 
Figure 9. Graphic display of Bayes’ theorem. As the pretest prob- 
ability (or population disease prevalence) of coronary artery disease 
(CAD) increases from left to right along the horizontal axis, the 
posttest probability of disease increases along the vertical axis. The 
chance of coronary disease is greater at any prevalence if the test is 
positive (predictive value, upper left curves) than if the test is 
negative (predictive error, lower right curves). The diagonal broken 
straight line going up from left to right shows the probability of 
disease in patients with nondiagnostic test results. These curves 
were calculated from the equations for Bayes’ theorem shown in the 
text, using the values of sensitivity (75%) and specificity (65%) for 
exercise electrocardiography (E, ECG), excluding patients with a 
nondiagnostic (non-DX) test. 
ingless to report predictive value or error without specifying 
the disease prevalence in that group. In fact, because prev- 
alence of disease in different patient populations can vary 
over a wider range (0.1% to 99.9%) than sensitivity or 
specificity of clinically useful tests (50% to 95%), one can 
conclude that prevalence is the most important factor influ- 
encing predictive value and error (36). Thus, we strongly 
recommend a subscript indicating disease prevalence below 
any published report of predictive value or error. 
Patients with a positive test are described by the curve in 
the upper left of Figure 8, which is always higher than the 
curve in the lower right for patients with a negative test. 
Figure 8 also shows that if a test is more accurate than 
another (for example, radionuclide scintigraphy versus ex- 
ercise ECG) then the chance of having coronary artery 
disease will be higher for any patient who has positive 
findings on the more accurate test than for a patient who has 
positive findings on the less accurate test (13,32,33). On the 
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other hand, if the specificity and sensitivity are higher, the 
chance that patient with a negative radionuclide study has 
coronary disease is less than that of a patient with a negative 
stress ECG. 
The equations for Bayes’ theorem are quite simple and 
intuitively reasonable (4,13,29,30,32,33). The probability of 
coronary artery disease in a patient with a positive test 
(predictive value) is related to test accuracy and the chance 
that disease is present in the group of patients having the 
test, as follows: 
True positives/(True positives t false positives). 
This equation is equivalent to: 
(Sensitivity) (Prevalence) 
(Sensitivity) (Prevalence) t (I -Specificity) (I-Prevalance) 
On the other hand, the probability of coronary artery disease 
in a patient with a negative test (predictive error) is: 
False negatives 
False negatives + True negatives 
This expression is equivalent to: 
(I -Sensitivity) (Prevalance) 
(I -Sensitivity) (Prevalence) t (Specificity) (I -Prevalence) 
Some authors report negative predictive value that is 
1 -predictive error or: 
True negatives 
False negatives t True negatives 
If the sensitivity and specificity of the test are known and 
the clinical data allow an estimate of the prevalence of 
coronary artery disease for the patient in question, the 
physician can calculate the chance that the patient has 
coronary disease on the basis of clinical information and a 
particular positive or negative test result (Fig. 7 and 8). If the 
sensitivity and specificity of tests are similar to those used in 
Figures 7 and 8, one can simply draw a vertical line from a 
point on the horizontal axis, where the patient data fit the 
prevalence of disease in the group, up to either the negative 
or the positive curve on the graph. 
An important clinical issue is what level of post-test 
probability is required to rule in or rule out coronary artery 
disease for an individual patient. A frequently used thresh- 
old is 5%, but this level could and should be varied to suit the 
clinical situation, as indicated in the next section (Question 
6). For some patients, the clinician would require the prob- 
ability to be ~2% to 3% to rule out coronary artery disease 
(for example, in a 40 year old airline pilot), whereas for 
others, 10% to 15% might be acceptable (for example, in a 70 
year old cancer patient). The main aim in estimating a 
probability of disease is to avoid an oversimplified diagnosis 
of disease from the test. On the basis of probability, the 
physician can decide what, if any, steps should be recom- 
mended. 
Bayes’s theorem is, indeed, clinically useful because it 
allows the physician to estimate the significance of a partic- 
ular positive, negative or nondiagnostic test result in the 
individual patient. This decision concerning the probability 
of disease based on the integration of clinical and laboratory 
data is a crucial step that must precede any decision about 
further management. 
Question 6 
What Farther Tests or Therapies Will the 
Physician Recommend for the Patient? 
The physician must actually ask this question before 
ordering the test. In this way, one can avoid the situation 
mentioned in the anecdote about the hypothetical 35 year old 
persona1 friend with a positive stress test. In other words, if 
the management plan would not change on the basis of a 
particular test result, the physician must ask whether the test 
would have any value (33). If the physician knows in 
advance that the management plan would not be changed by 
a positive or negative test result, the test is probably 
unnecessary. 
Another question to ask after the initial results are 
obtained is whether additional tests would be useful to help 
decide further management (Fig. 9). The physician can use 
Bayes’ theorem again by taking the patient’s pretest proba- 
bility of having coronary artery disease and recalculating it 
after the result of a first test is known. For example, with use 
of the exercise ECG, the revised probability of having 
disease can be substituted on the horizontal axis of Figure 8 
as the pretest probability with a radionuclide scintigram 
(5.33). In this way, the physician can assess whether per- 
forming radionuclide imaging after the results of the exercise 
ECG are known would provide a useful increment in infor- 
mation about the patient. 
Patient examples. As an example, neither a 35 year old 
woman without symptoms nor a 55 year old man with typical 
angina would likely benefit from an additional test such as 
radionuclide imaging, whatever the results of the stress ECG 
(5). The woman without symptoms has such a low probabil- 
ity of having disease that it would be changed only minimally 
by further testing. An important exception would be the use 
of exercise radionuclide testing instead of cardiac catheter- 
ization to reassure an anxious patient (or insurance com- 
pany) that the positive exercise ECG does not mean that 
coronary artery disease is present. 
On the other hand, the probability that a 55 year old man 
with angina has coronary disease is so high that a negative 
exercise ECG reduces it only to 40% to 50%, which is not a 
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clinically very useful difference (5). In contrast, if the woman 
were 45 instead of 35 years old and had atypical chest pain, 
her chance of having coronary artery disease before any test 
would be about 15% (Fig. 1) (1,2,4). If she then had a 
positive stress ECG, her chance of having coronary disease 
would be about 25% to 30% (Fig. 8). For a patient in this 
situation, performing radionuclide scintigraphy would be 
most useful. If radionuclide imaging results were negative, 
her chance of having coronary disease would be reduced to 
2% to 4%, a probability that would be quite useful clinically 
to stop the diagnostic evaluation and reassure the patient (5). 
Once again, these numeric values were simply read sequen- 
tially from Figures 1 and 8. The physician could not justify 
reassuring the 55 year old man with typical angina even if 
both noninvasive tests were negative, whereas the 35 year 
old ‘woman without symptoms would have such a low 
probability of having disease that a change in management 
with a positive test result would be unlikely. 
Here again, the physician’s opinion about the role of 
coronary surgery or angioplasty in improving longevity of 
patients with coronary artery disease plays an important 
role in test utilization. The physician who thinks that surgery 
substantially prolongs life in a large number of patients with 
coronary disease, should be quite aggressive in seeking to 
identify these patients. This aggressive approach and strong 
need to know might even lead the physician to recommend 
coronary angiography directly, rather than ordering nonin- 
vasive tests in patients when clinical information already 
suggests a moderate to high probability of coronary disease. 
On the other hand, a physician who is conservative and not 
convinced that coronary surgery is necessary in the vast 
majority of patients might use noninvasive testing more to 
identify high risk patients than to diagnose the presence of 
coronary artery disease or might use it as a guide for medical 
therapy. For example, a physician seeing an elderly patient 
on medical therapy for a presumed diagnosis of coronary 
disease might order a noninvasive test to rule out disease and 
allow stopping medications and avoiding future hospital 
admissions. The physician should have a clear objective and 
be consistent in applying his or her view of invasive thera- 
pies to the utilization of diagnostic tests. 
Statistical controversy (Table 6). There is some contro- 
versy concerning the usefulness of Bayes’ theorem as just 
described (37,38). It is assumed in Bayes’ theorem that the 
pretest clinical estimate of the probability of disease is 
conditionally independent of the results of the test itself 
(5,36-38). For example, the exercise ECG result should not 
depend on the clinical data. In one sense, they are not 
independent because a group of 55 year old men with typical 
angina and a 90% to 95% clinical probability of having 
coronary artery disease would also have a high probability of 
having a positive exercise ECG. Thus, these two separate 
types of data are not entirely independent in the sense that 
both clinical data and exercise test results would reveal 
physiologic consequences of coronary disease. Similarly, a 
group of 45 year old men with no symptoms or risk factors 
and a 3% clinical probability of having coronary disease 
would have a low probability of having a positive exercise 
ECG. One could argue that the clinical information is only 
related to the results of the noninvasive test because both 
provide assessments of the probability of coronary disease in 
the same group, assuming that the clinical information is not 
made known to the person interpreting the noninvasive test. 
The fact that a positive noninvasive test result is more likely 
in a patient whose clinical information also indicates a high 
probability of having coronary disease does pose a theoret- 
ical objection to this application of Bayes’ theorem (3638). 
Similarly, in one study (38), patients with a positive 
exercise ECG had a higher likelihood of positive exercise 
radionuclide imaging than did patients with a negative exer- 
cise ECG. If the total number of tests is small (fewer than 
five to eight), the violation of the assumption of independent 
predictions would not cause significant problems (39). Fur- 
thermore, Bayesian schemes have been validated to estimate 
the final probability of coronary artery disease from clinical 
information and serial noninvasive test results (40). In a 
population of > 1,000 patients, noninvasive predictions of 
coronary disease using Bayes’ theorem and serial tests 
correlated closely with actual prevalence of disease (40). 
A second question concerning the use of Bayes’ theorem 
to diagnose coronary artery disease is whether the sensitiv- 
ity and specificity of a test remain the same in different 
groups (36,37). Some data suggest that the sensitivity and 
specificity of the exercise treadmill test vary in groups with 
different prevalences of disease. For example, a sensitivity 
of 22% for the exercise ECG to detect coronary artery 
disease has been observed (41) in a group of relatively young 
women with “nonischemic chest pain.” That low sensitiv- 
ity, however, represented only two of nine patients. The 
sensitivity in this group with a 5% prevalence rate of disease 
was lower than that in the group as a whole (76%). In another 
exercise ECG study (42), sensitivity varied according to 
maximal exercise heart rate, number of diseased coronary 
arteries, type of chest pain, age and gender; specificity 
varied with maximal exercise heart rate. Hlatky et al. (42) 
concluded from these results that the assumption of constant 
values of sensitivity and specificity for Bayes’ theorem may 
be adequate for individual patient estimates in which the 
pretest probability of disease is always uncertain. In decision 
and cost-benefit analyses, however, these authors (42) indi- 
cated that the assumption of a constant sensitivity and 
specificity could lead to erroneous conclusions. 
Diamond (43) indicated that the results of this study by 
Hlatky et al. (42) could be explained by bias in selecting 
patients for cardiac catheterization based on a positive 
noninvasive test. Indeed, Diamond (43) plotted the data from 
the study by Hlatky et al. to indicate that 63% of the 
variation in sensitivity and specificity was explained by 
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Bayes’s theorem and selection bias. He offered a mathemat- 
ical approach to correcting the Bayesian estimates of disease 
probability for selection bias based on the total number of 
positive and negative tests in the population. One should 
note that the study by Hlatky et al. (42) does not seem to 
offer blinded readings of the exercise ECG and, as indicated 
above, this potential observer bias might contribute to the 
higher sensitivity observed in men with typical angina, older 
age and lower maximal exercise heart rate. The study by 
Hlatky et al. (42) may not have avoided observer bias but 
still provides useful information and concepts. Thus, the 
statistical assumptions in Bayes’ theorem may not apply to 
all clinical studies such as these where study patients were 
not chosen at random. In fact, the validation studies just 
cited (38-40) suggests that the use of Bayes’ theorem is 
clinically useful in randomly selected groups of patients. 
Multivariate analysis. The alternative statistical approach 
is multivariate or discriminant function analysis, using a 
large group of real patients to establish a reference data base 
of patients undergoing cardiac catheterization (Table 4) (44, 
45). Multivariate analysis offers the potential advantage that 
it may not assume the tests are independent of each other or 
that the sensitivity and specificity remain constant over a 
wide range of disease prevalence rates. Multivariate analysis 
to predict coronary artery disease, however, depends criti- 
cally on how patients were selected to establish the refer- 
ence data base. Thus. one might only be able to make 
reliable predictions in a group of patients similar to those 
referred for cardiac catheterization to the same institution at 
the time when the reference data base was being established. 
Reliability of probability estimate. It must be emphasized 
that the clinician can only estimate the probability of coro- 
nary artery disease, and there is a considerable margin of 
error using either Bayes’ theorem or multivariate analysis. 
When one understands that only an estimate can be achieved 
by the use of clinical and exercise test data, the potential 
differences between the use of Bayes’ theorem compared 
with multivariate analysis become small. Diamond and For- 
rester (46) have emphasized the important and useful differ- 
ence between the probability of coronary disease that is 
estimated versus the confidence that the physician has in 
that estimate of probability. Thus, one particular use of 
noninvasive testing is to validate the physician’s clinical 
estimate of the probability of coronary disease. In reality, 
many patients do not present a reliable history that allows 
the physician to define precisely his or her clinical or pretest 
probability of coronary disease. Such patients can be repre- 
sented on the graphs as having a broad range of clinical 
probabilities of coronary disease (Fig. 7 and 8). 
For ~xumplc, on one office visit, a patient may give a 
history typical of angina pectoris (induced by effort. relieved 
promptly by rest). but on the next visit, the patient may 
relate a different history of nonanginal chest discomfort (not 
related to exercise, lasting only seconds). In such patients, it 
will be useful to observe the response of their symptoms to 
exercise in the laboratory, as well as to use the ECG or 
radionuclide imaging data, or both, to define more narrowly 
the appropriate ranges of probability of coronary artery 
disease. Exercise testing is often performed in patients with 
an apparently high likelihood of having coronary disease 
based on clinical information. One must be cautious in 
concluding that this is always a waste of resources. The 
physician obtaining the clinical data will have the best 
perspective on how “soft” and potentially unreliable are the 
clinical data used to estimate the probability of disease in 
that individual patient. An objective test that confirms a very 
high or very low probability of coronary disease is very 
useful to the clinician-not only to change the estimate of the 
likelihood of disease-but also to increase his or her confi- 
dence that the estimate of coronary disease is correct. Also, 
in patients with a vested interest in the test result (for 
example, airline pilots on the one hand, and disability 
applicants on the other), noninvasive exercise tests may be 
quite useful as objective evidence for or against coronary 
disease to compare with the subjective history. In addition, 
there are numerous causes for a false positive clinical history 
(for example, musculoskeletal and cervical root pain) and a 
false negative history (for example, silent ischemia). Finally, 
the physician may order a stress radionuclide test in a patient 
with typical angina to assess prognosis and help decide 
whether or not the patient might benefit from coronary 
angiography. 
In summcl?. an important concept for the physician to 
keep in mind is that a noninvasive test result provides a 
better estimate of the probability of coronary disease if 
clinical information is also taken into consideration after 
objective test interpretation. Whether clinical data are com- 
bined with noninvasive tests using Bayes’ theorem or mul- 
tivariate analysis is of secondary importance (Table 6). The 
relative simplicity of understanding Bayes’ theorem 
(4.29,30.32,33.36) and using a nomogram (5) for its applica- 
tion offers certain practical advantages over the possibly 
more precise but more complex multivariate analysis. 
Question 7 
On Review of the Patient’s Situation, Were the 
Data Provided by the Particular Test or Tests 
Worth the Cost, Inconvenience and Risk for the 
Patient? Might Another Testing Strategy Have 
Provided Better Information? 
With this case by case self-assessment, the physician can 
continue to learn from personal experience. It is a useful goal 
in managing patients to try to limit the utilization of re- 
sources without compromising care, whether this involves 
the treadmill in one’s own office or in the nuclear cardiology 
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department of a hospital (47). Third party payers and gov- 
ernment are currently watching closely as the cost of health 
care increases to >lO% of the gross national product, and 
the care of patients with heart disease is >lO% of the total 
cost of health care (30). Performing no tests or less expen- 
sive tests does not always minimize the overall outlay of 
health care resources for a patient because, for example, 
exercise thallium imaging may ultimately save the financial 
and other consequences of false negative and false positive 
results of the less accurate exercise ECG (47). Thus, cost- 
effectiveness (defined as cost per effect of the test on quality 
and quantity of life) appears to be better for exercise 
thallium-201 than for the exercise ECG (47). Sometimes 
additional tests are needed to provide incremental informa- 
tion, as shown for the exercise ECG, in addition to clinical 
information (Fig. 8) and for exercise thallium-201 imaging in 
addition to the exercise ECG (Fig. 9). This concept of 
gaining incremental information from additional tests is 
discussed in more detail in the preceding section (Question 
6). It is possible to estimate the cost of this incremental 
information available from the additional test (47). Such 
considerations should be entertained by the physician as he 
or she discusses further testing with the patient. It is clear 
that more studies are needed to clarify the most economic 
use of health care resources, taking into account long-term 
consequences of erroneous test results and their complica- 
tions. 
Conclusions (Table 1) 
Noninvasive exercise tests for coronary artery disease 
are imperfect, and the information they provide is ~100% 
reliable despite attempts at quantification (48). The imper- 
fection of the tests is the rationale for developing an ap- 
proach such as the one described here. The seven questions 
proposed may help physicians determine their individual 
guidelines for the use of particular tests in evaluating pa- 
tients with potential coronary artery disease. The main issue 
in deciding the indications and usefulness of a noninvasive 
test is whether that test or another test will influence the 
physician’s actions or recommendations for further manage- 
ment. If the physician’s management would not be changed 
by a positive or negative test result, the indications for the 
test would be considered weak. On the other hand, the 
greater the change in management that would be effected by 
a positive or negative result, the stronger are the indications 
for the test (33). Often a low probability of coronary disease 
could be reduced to <5% by a negative test, and even a small 
change in the likelihood of coronary disease to ~5% would 
allow the physician to avoid additional tests to rule out 
coronary artery disease or a high risk anatomic situation (9- 
13). In this way, even a small change in probabilities might 
be very useful clinically. Patients to whom this situation 
would apply can be identified in advance by their having a 
relatively low clinical probability of coronary disease. By 
estimating their probability of disease by clinical information 
alone, and placing this on the horizontal axis of the graph of 
Bayes’ theorem in Figure 7, one can estimate the potential 
usefulness of a negative noninvasive exercise test. Bayes’s 
theorem simply provides a theoretical framework to com- 
bine the sensitivity and specificity of a noninvasive test with 
the clinical prediction of the probability of disease before the 
test to arrive at a more accurate final prediction of the 
chance of coronary disease. In a simplistic way, Bayes’ 
theorem represents a mathematical model for good clinical 
judgment (5). 
One could argue that under Question 2 an important 
management objective should be good care while expending 
only a reasonable amount of health care resources (47). This 
is a difficult goal for the cardiologist faced by a vast array of 
new technology. Even if a patient is wealthy and can afford 
to pay for the test, the facilities for performing nuclear 
cardiology tests, for example, may be overburdened by 
patients with marginal indications, causing long delays in 
obtaining tests that are more strongly indicated for other 
patients. Thus, the total cost to the health care system of 
ordering an unnecessary test may not be just financial, but 
rather may cause a patient who needs a test not to have it 
performed at an appropriate time. Adoption of a policy of 
appropriate (rather then redundant) utilization of health care 
resources by individual physicians could help assure that 
physicians, and not third party payers or government admin- 
istrators, will contribute to the resolution of these issues. 
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